Reply to "Residual Tumor Volume, Not Percent Cytoreduction, Matters for Surgery of Neuroendocrine Liver Metastasis"
- PMID: 37394671
- DOI: 10.1245/s10434-023-13839-z
Reply to "Residual Tumor Volume, Not Percent Cytoreduction, Matters for Surgery of Neuroendocrine Liver Metastasis"
Comment on
-
Residual Tumor Volume, Not Percent Cytoreduction, Matters for Surgery of Neuroendocrine Liver Metastasis.Ann Surg Oncol. 2023 Sep;30(9):5457-5458. doi: 10.1245/s10434-023-13834-4. Epub 2023 Jul 2. Ann Surg Oncol. 2023. PMID: 37394668 No abstract available.
References
-
- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)—Neuroendocrine and Adrenal Tumors. 2022. https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf .
-
- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)—Neuroendocrine and Adrenal Tumors. 2023. [Unpublished].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical